Prostate Cancer and Prostatic Diseases

(ISSN: 1365-7852, 1476-5608)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Articles Available on Medscape


Table of Contents

From Prostate Cancer and Prostatic Diseases

2021 -

  • Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial. 
  • Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data. 
  • Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide. 
  • Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer? 
  • Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England. 

Journal Information

Mission Statement: Prostate Cancer and Prostatic Diseases, covering all aspects of prostate disease (including BPH and cancer).